Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Thrombectomy, IVC filters & venous stents · New Jersey | Thrombectomy, IVC filters & venous stents · New York | |
|---|---|---|
| Surgeons, 2024 | 25 | 24 |
| Medicare fee-for-service cases | 1,782 | 2,696 |
| Growth since 2019 (Medicare FFS) | +1%/yr | −2.3%/yr |
| Forecast cases (Medicare FFS) | 1,690 in 2030 | 3,720 in 2030 |
| Forecast growth | −0.8%/yr to 2030 | +5.5%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 1.7 | 1.5 |
| Medicare Advantage share | 45% | 57% |
| Out of hospital | 28% (+17 pts since 2019) | 17% (−5 pts since 2019) |
| Cases per surgeon | 71 | 112 |
| Top 10 surgeons' share | 63% | 58% |
| Surgeons growing | 1 | 0 |
| New since the base year | 7 | 6 |
| Likely to stop billing it | 10 by 2026 | 16 by 2026 |
| Forecast miss, 1 year (procedure) | 9% | 9% |
| Company payments per surgeon | $8,896 | $45K |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.